Condition
C3 Glomerulopathy (C3G) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 C3 Glomerulopathy (C3G) clinical trials that are recruiting, at sites in 21 countries (most in Austria (2), Belgium (2), Czechia (2)). By phase: Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 21Countries
All recruiting trials (2)
-
Pegcetacoplan in real-world C3G and IC-MPGN patients
This study tests pegcetacoplan's safety and effectiveness in people with C3 glomerulopathy or primary IC-MPGN in real-world practice.
-
CPV-104 safety and drug processing in healthy adults and people with C3 glomerulopathy
This trial tests whether CPV-104 is safe, how the body processes it, and whether the immune system reacts to it in healthy adults and adults with C3 glomerulopathy.
Related topics
Quick answers
How many C3 Glomerulopathy (C3G) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 21 countries. The most sites are in Austria (2 trials), Belgium (2 trials), Czechia (2 trials), France (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.